Clinical Trial Update: Spironolactone Safety in African Americans With Mild Cognitive Impairment and Early Dementia [Phase 4]

View source ↗

Summary

The Phase 4 trial update notes the completion of a study evaluating the safety of spironolactone in African Americans with Mild Cognitive Impairment and early A…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Cognitive Impairment

Drugs mentioned

• Spironolactone (spironolactone)

Snippet

Sponsor: Emory University | Conditions: Mild Cognitive Impairment, Alzheimer Disease | Phase 4 | Status: COMPLETED